Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5 years of treatment (SCULPTURE Extension Study)
Journal of the European Academy of Dermatology and Venereology | Aug 30, 2018
Hospital readmissions among patients with skin disease: A retrospective cohort study
Journal of the American Academy of Dermatology | Aug 25, 2018
Voriconazole exposure and risk of cutaneous squamous cell carcinoma among lung or hematopoietic cell transplant patients: A systematic review and meta-analysis
Journal of the American Academy of Dermatology | Aug 23, 2018